Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01553539 · OUTCOME

Number of Participants Who Experienced Adverse Events as Assessed by Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery · Source last updated 2018-07-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Participants experiencing adverse events
Interval / dispersion
Not reported
Time frame
Approximately 1 year

What was measured

See the adverse event tables for specifics.

Groups in this outcome

Treatment (Antiangiogenesis Therapy)

Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Antiangiogenesis Therapy)20

Reported measurements

Source class 1
Values in Participants experiencing adverse events · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)20Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        20
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
See the adverse event tables for specifics.
groups
  1. description
    Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.
    id
    OG000
    title
    Treatment (Antiangiogenesis Therapy)
param Type
NUMBER
reporting Status
POSTED
time Frame
Approximately 1 year
title
Number of Participants Who Experienced Adverse Events as Assessed by Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0
type
PRIMARY
unit Of Measure
Participants experiencing adverse events

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice